𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958–1996

✍ Scribed by Kari Hemminki; Xinjun Li; Pauli Vaittinen

Book ID
117459119
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
303 KB
Volume
101
Category
Article
ISSN
0301-2115

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

International trends in the incidence of
International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas
✍ A. Paloma Vizcaino; Victor Moreno; F. Xavier Bosch; Nubia Muñoz; Xoán M. Barros- 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 152 KB 👁 3 views

Time trends in the incidence of cervical adenocarcinoma and adenosquamous cell carcinomas during the period 1973-1991 were examined using data provided by 60 populationbased cancer registries from 32 defined populations in 25 countries. Three components of the incidence trend were studied: age, cale

Cervical adenocarcinoma and squamous cel
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000
✍ Sophia S. Wang; Mark E. Sherman; Allan Hildesheim; James V. Lacey Jr.; Susan Dev 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

## Abstract ## BACKGROUND Although cervical carcinoma incidence and mortality rates have declined in the U.S. greatly since the introduction of the Papanicolaou smear, this decline has not been uniform for all histologic subtypes. Therefore, the authors assessed the differential incidence rates of

Incidence trends and survival of penile
Incidence trends and survival of penile squamous cell carcinoma in the Netherlands
✍ Niels M. Graafland; Rob H.A. Verhoeven; Jan-Willem W. Coebergh; Simon Horenblas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 287 KB 👁 1 views

## Abstract We examined trends in the incidence and mortality, and described the survival of patients with penile squamous cell carcinoma in the Netherlands between 1989 and 2006. On the basis of nationwide population‐based data, 3‐year moving average European age‐standardized incidence and 10‐year